» Articles » PMID: 35888093

Androgens Tend to Be Higher, but What About Altered Progesterone Metabolites in Boys and Girls with Autism?

Overview
Journal Life (Basel)
Specialty Biology
Date 2022 Jul 27
PMID 35888093
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence exists that steroid hormones are altered in individuals with autism, especially androgens. Despite lower prevalence in girls than boys, evidence of potential alterations in progesterone metabolites is sparse, so the aim of this study was to elucidate different progesterone metabolites in affected children with autism versus healthy controls. Material and Methods: Circadian urine samples from 48 boys and 16 girls with autism spectrum disorders and a matched case−control group were analysed for progesterone metabolites by gas chromatography−mass spectrometry and normalised for creatinine excretion. Results: In boys with autism, the majority of progesterone metabolites were reduced, such as progesterone, 6a-OH-3a5b-TH-progesterone, or 20a-DH-progesterone (p < 0.01 for all). In girls with autism, a similar pattern of reduction in progesterone metabolites was detected; however, potentially due to the relatively small sample, this pattern was only detectable on the level of a trend. Discussion: As stated, androgen levels are higher in boys and girls with autism, but evidence for progesterone metabolites is much sparser. The pattern of a decrease in progesterone metabolites suggests the existence of an altered routing of steroid metabolites, probably in combination with a dysregulation of the HPAG axis. As, recently, increased CYP17A1 activity has been suggested, the stronger routing towards androgens is further implied in line with our findings of lower progesterone concentrations in boys and girls with autism than healthy controls.

Citing Articles

Steroidogenic pathway in girls diagnosed with autism spectrum disorders.

Jansakova K, Hill M, Celusakova H, Repiska G, Bicikova M, Macova L PLoS One. 2024; 19(12):e0312933.

PMID: 39636905 PMC: 11620458. DOI: 10.1371/journal.pone.0312933.

References
1.
Gillberg C, Fernell E, Kocovska E, Minnis H, Bourgeron T, Thompson L . The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: A hypothesis paper. Autism Res. 2017; 10(6):1022-1044. PMC: 5485071. DOI: 10.1002/aur.1777. View

2.
BAULIEU E, Schumacher M . Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids. 2000; 65(10-11):605-12. DOI: 10.1016/s0039-128x(00)00173-2. View

3.
Crider A, Thakkar R, Ahmed A, Pillai A . Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects. Mol Autism. 2014; 5(1):46. PMC: 4161836. DOI: 10.1186/2040-2392-5-46. View

4.
Strifert K . The link between oral contraceptive use and prevalence in autism spectrum disorder. Med Hypotheses. 2014; 83(6):718-25. DOI: 10.1016/j.mehy.2014.09.026. View

5.
Baron-Cohen S, Auyeung B, Norgaard-Pedersen B, Hougaard D, Abdallah M, Melgaard L . Elevated fetal steroidogenic activity in autism. Mol Psychiatry. 2014; 20(3):369-76. PMC: 4184868. DOI: 10.1038/mp.2014.48. View